chrisvoncsefalvay/vaers-outcomes huggingface dataset:
she had a rash all over her body except for the bottom of her feet.; her back was itching so bad; Scabs from scratching; This is a spontaneous report from a contactable consumer (patient). A 74-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: EN6207), via an unspecified route of administration on 17Mar2021 (at the age of 74-years-old) as dose 2, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: EN6201), via an unspecified route of administration on 24Feb2021 as dose 1, single for COVID-19 immunization. Patient reported that 3 days after (20Mar2021) she received the Covid-19 vaccine, she had a rash all over her body except for the bottom of her feet. She had gone to doctor and they have given her prednisone, creams, and different things to treat the rash. She reported that she could not get into the dermatologist because there was no availability and the first available appointment is in Jul2021. She further reported that she lived on Benadryl and she does not know what else to take, she had anti-itch creams and Benadryl and she does not know what to take anymore. She reported that she had seen her regular doctor and her physician, stated that he couldn't believe the rash that she had. She saw her gynecologist also, her gynecologist stated that she couldn't believe the rash that the patient had. Gynecologist said that the caller had scabs (2021) all over her because of how much the patient was scratching. Patient also reported that she had changed nothing since receiving the second dose of the Covid-19 vaccine, she was not taking any new medications and had not changed soap or detergent. She reported that on 28Apr2021 also her back was itching (20Mar2021) so bad, she did not care what she picked up to scratch her back, she had scratched herself with a comb, a back scratcher, and the hard metal part of her dogs brush and reported that there was nothing on her face and nothing on the soles of her feet with the rash. She stated that there were some days where the rash and itching seemed like maybe they were getting a little better but then it went back to where it was, she did not know if her rash and itching had improved, persisted, or worsened. The patient received treatment for the events. The clinical outcome for the events was not recovered.  No follow-up attempts are needed. No further information is expected.
pt c/o sore throat, swollen glands, chills, sweats & body aches; also cold s/s; no local reaction; MD checked & stated it was not flu shot related;
Patient reported a 15 second intense burning at subcutaneous injection site followed by a warm sensation down his affected arm.  The patient reports "redness and swelling developed quickly at the injection site (which I understand is not uncommon for that vaccine) with a large (2-3 cm), palpable, mass in the deeper tissue.  There was also considerable itching over the next few days.  The mass finally disappeared after about five days, and the redness is much smaller in diameter (from several centimeters down to 2.5 to 3 cm today). "
Pt was given expired vaccine on 07/22/2005 TriHiBit (DTaP + Hib) Error was discovered 07/25/2005. Meds expired 07/12/2005. No adverse reaction. Pt mother notified. Revaccination on 08/05/2005
Day after vaccine- sore arm, body aches, headache 2/6/22- frequent heart palpitations, chest aches 2/17/22- was seen by NP, ran blood work and referred me to Cardiologist 2/24/22- Cardiologist recommended not to get booster, ran ecg- normal, placed on heart monitor and will have ultrasound completed. Unknown cause at this time.
significant discomfort in the injection area; soreness injection site; This is a spontaneous report from a contactable consumer. A 57-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 19Mar2021 at 10:30 (at the age of 57-year-old) as a single dose for COVID-19 immunisation. Medical history included hyperthyroidism and blood pressure high. Patient previously received sulfamethoxazole for an unknown indication on an unknown date and experienced drug allergy. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN), SYNTHROID, ezetimibe (MANUFACTURER UNKNOWN) and melatonin (MANUFACTURER UNKNOWN), all for unknown indications from an unknown dates. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date, the patient underwent nasal swab test and the result was negative. On 20Mar2021, the patient experienced vaccination site discomfort and vaccination site soreness. Its reported that  approximately 24 hours after the initial vaccine was administered patient experienced significant discomfort in the injection area that had been increasingly worse and sustained since the administration date with no improvement in discomfort and soreness. The events resulted in doctor or other healthcare professional office/clinic visit (discussed with pcp). The clinical outcome of the events of vaccination site discomfort and vaccination site pain were not recovered at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Arm was sore after vaccine; This is a spontaneous report from a contactable consumer. This consumer reported for a 40-year-old male patient that received BNT162B2 (COVID vaccine), via an unspecified route of administration on unknown date at single dose for covid-19 immunisation.  The patient medical history and concomitant medications were not reported. Arm was sore after vaccine. The outcome of the event was unknown.   Information on the lot/batch number has been requested.
ill and not feeling well; ill and not feeling well; bad eye pain; This is a spontaneous report from a Pfizer Sponsored Program  Support via a contactable consumer reported for a patient (Mother). A 85-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: unknown, Expiration date: unknown) via an unspecified route of administration, administered at an unspecified anatomical location on 04Feb2021 (age at vaccination was unknown) as dose 1, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date in Feb2021, the patient was ill and not feeling well and experienced bad eye pain. The patient was scheduled for the 2nd dose on 25Feb2021 (exactly 21 days apart). The caller claimed that the patient was unable to make it that day and wanted to reschedule her 2nd dose since the patient was currently ill and not feeling well. The caller asked to reschedule the patient's vaccination schedule that day since the patient experienced bad eye pain. The outcome of the events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient did not have any adverse effects.` The vaccine administered was 50mcg of the pediatric vaccine instead of the bivalent vaccine.   This writer informed patient and Dr.Per Dr will administer bivalent vaccine in 8 weeks. Patient was not seen.
Began to develop a slight brain fog one hour upon dose administration. Otherwise mild. Went to bed at 11:00 pm and woke up at 2 am with heart thumping with pulse beating around 70 beats per minute. Became highly attuned to it and experienced tacychardia at 118 (generally resting heart rate is extremely low). Seemed to return to 70 with some breathing exercises and returned to sleep. Woke up the next morning with flu symptoms and the works - felt worse than original Covid in October. Flu like symptoms seemed to pass by Monday. However, pulse remained elevated through the week by about ten points and noticed hypertension. BP 150/95 Wednesday and 160/100 on Friday. Went to ER Friday night with BP 188/117 and tachycardia. Vitals and blood work all normal however confusion as to why BP remains elevated despite Thursday before vaccine being 132/82. Left hospital with BP 154/95. Palpatations and thumping chest have continued throughout the week. As well as general fatigue and fog behind the eyes.
Pleuritic chest pain (pain with breathing/laughing) & L upper abdominal pain with radiation to clavicle/scapula.  ER visit on 10/28, CT scan dxed with small, L lung base atelectasis vs. infiltrate and small L pleural effusion. 11/18/09:  ED records received for date of service 10/22/09. Dx:  Pleuritic chest pain. Assessment:  Presents with c/o abdominal pain, hurts to breathe.
October 9th, I stepped backwards and broke my foot and I have never broken a bone before; So, patient asked the doctor to check her TSH, actually in June, her TSH level had fallen, signaling Thyroid difficulty, it was always within the normal range before; Graves' disease; This is a spontaneous report from a contactable consumer (Patient). A 63-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number: ER8733), via an unknown route of administration into left arm on 01Apr2021, as dose 2, single (Age at vaccination: 63-year-old) for Covid-19 immunization. Medical history included: High blood pressure and Concomitant medications included: NEBIVOLOL HYDROCHLORIDE (Bystolic), Vitamin D at 1000 IU, and simvastatin. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number: EN6199), via an unknown route of administration into left arm on 10Mar2021 as dose 1, single (Age at vaccination: 62-year-old) for Covid-19 immunization and experienced Eye problems, had a migraine; It was followed by flashing lights in her left eye. She had more eye problems like a stabbing pain in her eye. The patient had an MRI scan (results unspecified), a TSH eye which found to be within normal range. The patient went to the eye doctor, and they put her on a steroid for 2 weeks and then they had her on an antibiotic and patient was still on it. The patient mentioned treatment medications for eyes problem as Neomycin for 3 weeks and switched to Erythromycin eye gel. The patient had no prior vaccinations (within 4 weeks). The patient had test done for Graves disease. This summer, she had a few symptoms, not really many but then, on 09Oct2021, she stepped backwards and broke her foot. The patient stated that she had never broken a bone before. The patient had TSH test done, and her levels were found to have fallen and signaled Thyroid difficulty. TSH decrease on an unspecified date in Jun2021. The patient thyroid value was found to be even lower after she broke her foot. Her antibody test result was 0.38 on 16Mar2021, 4 to 5 days after she got her first COVID shot, and it was 3.72 at the time of reporting. The patient had Grave's disease on an unspecified date in 2021. Laboratory data included: 3T4 and result was 1.20, within the normal range. she had, these all done on 22Oct2021, T33 was 3.86 and it was high. Then, Thyroid simulating Immunoglobulin (TSI), it was 3.72 and the reference range was up to 0.55. And then, she did Sedation, SED rate was 18, it was in the normal range. TSH was suppressed and the T3 was slightly elevated working at earlier point. TSH decrease on an unspecified date in Jun2021. Events (Grave's disease and foot fracture) were assessed as serious (medically significant) and TSH decrease was assessed as non-serious. Outcome of events was unknown.   Follow-up attempts are completed. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101487625 Same patient and drug, different event separated in time
Delayed itchiness, redness and soreness at injection site. Lasting approximately 24 hours.
expired vaccine used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired vaccine used) in a 73-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Nov-2021 at 11:22 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 04-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired vaccine used). On 04-Nov-2021, EXPIRED PRODUCT ADMINISTERED (expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.
Low energy, muscle weakness, pain, increased stomach pain, high fever 102, no appetite, chills, sleeping all day, glazed eyes, body pain all over, excessive crying. Two days later continuing for a week-Sore throat and runny nose over all feeling sick.
Fever 101 degrees, eyes swollen. tightness in chest, body aches.  MOTRIN for temperature and aches.
I had severe mid back pain lasting 4 weeks, followed by neck pain 2-3 days, followed by lower back pain for 1 day, followed by left knee pain for 1 day and finally followed by right knee pain for about 5+ weeks.  I do suffer from occasional back pain but never suffered from any knee pain
It started two weeks after getting vaccinated. I lost my balance and vertigo. I was out walking my dog, I fell and I hit my head on a tree root, I was knocked out for about 5 1/2 hour. When I came to I was laying on the ground and I had cuts and scratches on my face, elbow and my back. I can't remember much of that fall. I walked home and went to bed. I didn't go to the doctor.
2 days following administration of Shingrix at local community pharmacy, patient presents to PCP with eyelid swelling and shingle-like rash over eye. PCP started valacylovir and Bactrim for shingles and facial cellulitis. Patient presents the next day (10/17/19--4 days post injection) to the ED for continued rash and feeling uncomfortable.
Patient got an accidental third dose; This case was reported by a other health professional via call center representative and described the occurrence of extra dose administered in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (Received 1st and 2nd dose in 2018).   On an unknown date, the patient received the 3rd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced extra dose administered. On an unknown date, the outcome of the extra dose administered was unknown.  Additional details were reported as follows: The age at vaccination was not reported. The reporter was anonymous Healthcare professional. The reporter stated that, they had the patient who told them she never had a shingrix vaccine and got one in December. She came back for the second one and found out she had the 2 shot series in 2018 already and dose received in December (year not specified), was a 3rd dose of Shingrix, which led to Extra dose administered. The reporter queried about any risk or literature of getting an accidental third dose. The reporter disconnected the chat before credentials could be gathered. No additional information available. The reporter did not consent to follow up.
Woke up shaky, weak, diaphoretic, nauseous, dizzy/vertigo (patient NOT a diabetic). In case it was low blood sugar, patient ate apple sauce, a piece of a banana, some macaroni, and drank approximately 500mL of water. The symptoms continues with new onset fatigue. After sleeping off and on for several more hours the symptoms slowly began to resolve. Current time is 12:15 AM on 12/17/11- 8 hours after onset of symptoms and nearly 16 hours after vaccination was administered- and patient is finally able to walk appropriately, the vertigo and nausea have subsided, but the patient remains feeling sluggish.
This case was reported by a pharmacist via call center representative and described the occurrence of erythema in a 78-year-old female patient who received SHINGRIX (batch number T5242, expiry date 31st March 2020). On 13th March 2018, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. On 14th March 2018, 1 days after receiving SHINGRIX, the patient experienced erythema (serious criteria disability), dizziness (serious criteria disability) and pain (serious criteria disability). On an unknown date, the outcome of the erythema and pain were not recovered/not resolved and the outcome of the dizziness was recovering/resolving. The reporter considered the erythema, dizziness and pain to be related to SHINGRIX. Additional details were reported as follows: At 12:30, the patient received SHINGRIX on left arm. The patient experienced redness and soreness of her arm and also dizziness reporting day morning to the point where she felt like she was going to pass out. The patient believed the medication was given subcutaneously instead of intramuscular but the pharmacist noted the documentation was noted as intramuscular. The pharmacist was not the administering pharmacist and planned to speak with the pharmacist. Warm transferred to Medical Information System.
5/22 having mid central chest pain, shortness of breath, hurts when breathing in.
I was about 20 weeks pregnant when I received my first dose, I am due 1/16/22. I had my first fetal growth scan at 22 weeks, and I follow up one at 28 weeks. During that scan, it was discovered the baby was a bit small for their gestational age. I had an additional scan at 30 weeks with a specialist, where they advised the baby is smaller and has a small head. Their head is measuring in the 2nd percentile and their body is measuring in the 32nd percentile. My Trisomy blood test all came back fine, neither I nor the father have any family history of microcephaly.  I have had I have a two-year-old who was carried to term. 42 weeks to be exact, a large baby, 8 pounds, 7 ounces and 32 inches long.
After the third booster she had a lot of pain in her arm, booster hurt way more than any of the shots she had previously; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 63-year-old female patient received BNT162b2 (BNT162B2), on 20Apr2021 as dose 2, single (Lot number: FJ1611) at the age of 62 years for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: BNT162b2 (DOSE 1, SINGLE; Lot number: EW0150), administration date: 30Mar2021, when the patient was 62-year-old, for COVID-19 Immunization, reaction(s): "After the third booster she had a lot of pain in her arm, booster hurt way more than any of the shots she had previously". The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "After the third booster she had a lot of pain in her arm, booster hurt way more than any of the shots she had previously".  Additional information: The patient had no other conditions.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201118303 same reporter/patient/event, different dose;
Pt received her first dose of the Moderna COVID19 vaccine Oxygen Sat 95%  HR 102 BP 190/90 BP recheck 10 minutes later 158/78 HR 78 Pt reported feeling ?queasy? and unwell about 10 minutes after vaccination. Pt was evaluated by Prospect EMS paramedic. Pt reported being very afraid and nervous that the vaccine implanted a micro chip in her and she is scared she is going to start ?.? Pt signed refusal for transport to the hospital with Prospect EMS. Pt reported feeling better.
Hospitalized for COVID 19 on 6-22-22 and died on 7-18-22
Case PHEH2016US025141 is an initial spontaneous report received from pharmacist on 27 Sep 2016. This report refers to unknown demographics. Medical history and concomitant medication was not reported. The patient was vaccinated with single dose of FLUCELVAX Quadrivalent (batch number and expiry date: not reported) on an unknown date. On an unspecified date, the patient had egg allergy. The outcome, seriousness and causality of event were not reported.
This spontaneous report as received from a registered nurse refers to multiple number of patients of unknown aeg and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical history provided. On an unknown date, the patients were vaccinated with doses of VAQTA (dose and route of administration not reported) lot # L009445, expiration date 01-JUN-2017, that were improperly stored. There were no adverse effects reported. No PQC (product quality complaint) was involved. This is one of several reports received from the same reporter. Additional information has been requested.
Information has been received from a registered nurse concerning a female (age not reported) who an unspecified date was vaccinated intramuscularly with a 0.5 ml dose of Gardasil (yeast) (lot number not reported). The nurse reported that the patient, after receiving the Gardasil (yeast), did not receive her next expected period. The patient sought unspecified medical attention. At the time of this report, the outcome was unknown. Additional information has been requested.
burning rash /hives on back of head  treatment zertec  .  less red   ,less burning after 1 hour .
Menstrual cycle started one week after injection, experience 5-10 blood clots larger than the size of a quarter
I  received the vaccine at 4:55 pm and my symptoms started at 11pm sneezing and running nose  the next day I had a really bad headache and congested day 3 oct 3rd 2021 congested nd coughing.
The patient received the Menactra vaccine on 4//06.  She developed right sided Bells Palsy on 4/27/06.  She was evaluated in the ER and was sent home on Prednisone and Acyclovir.  She was admitted 4/29/06 for emesis and inability to tolerate p.o.  She was discharged after 24 hours.  She continues to have Bell's Palsy and is being evaluated by a neurologist today. 60 day Follow-up Information 01-AUG-2006: Acc. to reporter, the patient continues to have diff. closing R eye lid. She is being referred back to Neurology.
Dizziness Dry Mouth Narrative:  Light headed and dry mouth. BP 122/75 HR 83 O2 Sats 98%.
Patient received the J and J vaccine on 10/1/21. He noticed on 10/4/21 that his right side of his face was drooping. He presented to a walk in clinic on 10/5/21 and diagnosed with Bells Palsy. He denies any other complications or side effects. He was prescribed prednisone and advised to follow up with his primary care doctor in 2-3 days.
After receiving the vaccine I had a sore arm. On April 15, 2022 I had a mammogram, and he doctor said they saw something on it. On April 21st I had another mammogram. On May 5th I had a biopsy, and they saw calcification in my left breast. I went back on May 10th, and they said that I have Lobular carcinoma in situ (LCIS). Since then they sent me to a cardiologist on May 11th. I had a nuclear stress test and cardiogram on May 17th. On May 18th I had a MRI of both breast. I go back on May 20th. On May 23rd they are going to implant a magnesium feed. I have a surgery set up on May 24th for a guided excisional biopsy. I have a follow up on June 1, 2022 after surgery.
Patient advised that noticed rash at bedtime (11:30 PM) on 4/14/12 with itching. Woke up at 2AM 4/15/12 with burning pain on right side between hip joint & wrist. Burning pain has become worse. Pain localized to right side. Advised patient to see physician - was going to MD evening of 4/19/12. MD's office was also called approx 5:45 on 4/19/12 & incident reported to employee in MD's office.